1. charlie4500kelly
2. falkev01
3. bcavage
4. geocansan
5. DontGiveMeLip
1.geocansan 08/30/2018
Mesoblast Provides Update on Transaction With Tasly Pharmaceutical Group
2.bcavage 05/29/2018
Mesoblast Partners With Cartherics to Develop 'off-the-shelf' Cell-based Immunotherapies for Solid Cancers
3.falkev01 04/19/2018
Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart Failure
4.falkev01 02/21/2018
Big moves ahead
5.DontGiveMeLip 06/07/2018
H.C. Wainwright & Co. initiates coverage with Buy rating, $17 PT
6.charlie4500kelly 02/21/2018
OK let's see what happens now......
7.charlie4500kelly 03/29/2018
Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment
8.charlie4500kelly 02/21/2018
Reports Phase 3 trial of allogeneic mesenchymal stem cell candidate MSC-100-IV in children
9.falkev01 05/01/2018
Mesoblast Cell Therapies Featured at Vatican International Healthcare Conference
10.charlie4500kelly 01/31/2018
Maxim Group reiterates Buy rating, $14 PT
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW